Merit Medical Systems, Inc. logo

MMSI

Merit Medical Systems, Inc.

$61.15

Earnings Summary

Revenue
$294.98Mn
Net Profits
$15.3Mn
Net Profit Margins
5.19%
PE Ratio
61.73

Highlights

Revenue:

Merit Medical Systems, Inc.’s revenue jumped 5.23% since last year same period to $294.98Mn in the Q2 2022. On a quarterly growth basis, Merit Medical Systems, Inc. has generated 7.1% jump in its revenue since last 3-months.

Net Profits:

Merit Medical Systems, Inc.’s net profit jumped 211.19% since last year same period to $15.3Mn in the Q2 2022. On a quarterly growth basis, Merit Medical Systems, Inc. has generated 45.07% jump in its net profits since last 3-months.

Net Profit Margins:

Merit Medical Systems, Inc.’s net profit margin jumped 195.73% since last year same period to 5.19% in the Q2 2022. On a quarterly growth basis, Merit Medical Systems, Inc. has generated 35.45% jump in its net profit margins since last 3-months.

PE Ratio:

Merit Medical Systems, Inc.’s price-to-earnings ratio after this Q2 2022 earnings stands at 61.73.

Earnings per share (EPS) Estimates

Earnings per share (EPS) estimates of the Merit Medical Systems, Inc. post its latest quarter earnings

EPS Estimate Current Quarter
0.54
EPS Estimate Current Year
0.54

Highlights

EPS Estimate Current Quarter:

Merit Medical Systems, Inc.’s earning per share (EPS) estimates for the current quarter stand at 0.54 - a -6.9% fall from last quarter’s estimates.

EPS Estimate Current Year:

Merit Medical Systems, Inc.’s earning per share (EPS) estimates for the current year stand at 0.54.

Key Ratios

Key ratios of the Merit Medical Systems, Inc. post its Q2 2022 earnings

Earning Per Share (EPS)
0.73
Return on Assets (ROA)
0.05
Return on Equity (ROE)
0.06
Dividend Per Share (DPS)
0

Highlights

Earning Per Share (EPS):

Merit Medical Systems, Inc.’s earning per share (EPS) jumped 17.74% since last year same period to 0.73 in the Q2 2022. This indicates that the Merit Medical Systems, Inc. has generated 17.74% annual rate of jump in its earning per share (EPS) in the last 4 quarters.

Return on Assets (ROA):

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Merit Medical Systems, Inc.’s return on assets (ROA) stands at 0.05.

Earning Per Share (EPS):

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Merit Medical Systems, Inc.’s return on equity (ROE) stands at 0.06.

Dividend Per Share (DPS):

Merit Medical Systems, Inc. declared 0 dividend per share during the earnings announcement for Q2 2022.

Earnings Calendar

Earnings DateEstimated EPSReported EPSSurprise %
2022-05-06
0.47
0.53
12.77%
2022-06-30
0.58
0.73
25.86%

Company Information

Founded in 1987, Merit Medical Systems, Inc. is a leading manufacturer and marketer of proprietary disposable medical devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology, oncology, critical care and endoscopy. Merit serves client hospitals worldwide with a domestic and international sales force and clinical support team totaling in excess of 500 individuals. Merit employs approximately 6,000 people worldwide with facilities in South Jordan, Utah; Pearland, Texas; Richmond, Virginia; Rockland, Massachusetts; Aliso Viejo, California; Maastricht and Venlo, The Netherlands; Paris, France; Galway, Ireland; Beijing, China; Tijuana, Mexico; Joinville, Brazil; Ontario, Canada; Melbourne, Australia; Tokyo, Japan; Reading, United Kingdom; Johannesburg, South Africa; and Singapore.

Organisation
Merit Medical Systems, Inc.
Headquarters
South Jordan, Utah, US
Employees
5.99K
Industry
Health Technology
CEO
Fred Lampropoulos